Electrochemiluminescence in Bioanalysis

10.1021/ja00972a052

10.1021/ja00801a011

10.1021/ac00133a017

10.1021/ja00763a056

10.1111/j.1751-1097.1971.tb06098.x

10.1007/s00216-007-1631-2

10.1021/cr068083a

10.1021/ja00393a006

10.1021/ja00458a028

10.1021/ja00541a080

10.1016/0378-4347(94)00519-B

10.1002/elan.200603555

10.1021/ja00392a022

10.1149/1.2086171

10.1002/anie.200603491

10.1021/ac981322c

10.1016/j.elecom.2007.08.017

10.1021/cr020373d

10.1038/377758a0

10.1093/clinchem/37.9.1534

10.1201/9780203027011

Yang H , LelandJK, YostD, MasseyRJ. Electrochemiluminescence: a new diagnostic and research tool. ECL detection technology promises scientists new “yardsticks” for quantification. Biotechnology (NY)12, 193–194 (1994).

10.1016/j.talanta.2006.02.063

10.1002/chem.200700068

10.1002/1522-2683(200211)23:21<3683::AID-ELPS3683>3.0.CO;2-F

10.1016/S0003-2670(97)00157-8

10.1002/1521-4109(200211)14:22<1571::AID-ELAN1571>3.0.CO;2-X

10.1128/jcm.16.1.141-144.1982

10.1039/an9901501145

10.1128/aem.57.9.2693-2698.1991

10.1099/00222615-32-4-233

10.1128/aem.61.5.1714-1719.1995

10.1002/cyto.990160102

Collins CH , LynePM, GrangeJM. Microbiological Methods (6th Edition). Butterworth–Heinemann Publishing, Oxford, UK (1989)

10.1093/ajcp/101.1.91

10.4269/ajtmh.2001.65.1.11504397

10.1016/0956-5663(95)96925-O

10.1128/aem.62.2.587-592.1996

10.1016/S0022-1759(98)00047-7

10.1128/CDLI.10.4.506-513.2003

10.1016/S0956-5663(99)00068-8

Abbas AK , LichtmanAH, PillaiS. Cellular and Molecular Immunology (6th Edition). Saunders Inc., PA, USA,563 (2007).

Murphy K , TraversP, WalportM. Immunobiology (7th Edition). Garland Science, NY, USA (2008).

Fernandez-Botran R , VetvickaV. Methods in Cellular Immunology. CRC Press, Inc, FL, USA (1995).

Harlow E , LaneD. Using Antibodies: A laboratory Manual. Cold Spring Harbor, NY, USA (1999).

10.1016/S0022-1759(97)00081-1

10.1016/S0022-1759(03)00007-3

10.1038/sj.tpj.6500325

10.1164/rccm.200601-066OC

Gomperts BD , TathamPE, KramerIM. Signal Transduction. Academic Press, CA, USA (2002).

10.1128/MCB.01456-06

10.1016/j.imlet.2007.08.013

10.1074/jbc.M703694200

10.1124/jpet.106.110387

10.1002/eji.200838170

10.1182/blood-2007-04-084756

10.4049/jimmunol.180.5.3520

10.4049/jimmunol.180.10.6868

10.4049/jimmunol.136.7.2348

Paul WE . Fundamental Immunology (5th Edition). Lippincott Williams & Wilkins, PA, USA (2003).

10.1172/JCI28508

10.4049/jimmunol.181.9.5948

10.1084/jem.20071258

10.1016/j.jaci.2007.08.059

10.1542/peds.2006-3150

10.1158/1535-7163.MCT-07-0118

10.1093/jnci/djm083

10.1016/S0002-9378(15)30003-X

10.1034/j.1600-0897.2003.00042.x

10.1124/mol.107.042176

Fried MW . Side effects of therapy of hepatitis C and their management. Hepatology36(5) (Suppl. 1), S237–S244 (2002).

10.1016/j.antiviral.2003.08.009

10.1086/339042

10.1097/01.qai.0000221689.77220.42

10.1093/oxfordjournals.aje.a009276

Fichorova RN . Guiding the vaginal microbicide trials with biomarkers of inflammation. J. Acquir. Immune Defic. Syndr. 37(Suppl. 3), S184–S193 (2004).

10.1128/JVI.75.17.8195-8202.2001

10.1128/JVI.75.13.5812-5822.2001

10.1086/315514

10.1016/S0923-2494(05)80036-7

10.1128/AAC.00588-06

10.1038/nrmicro729

10.1503/cmaj.1041462

10.1097/00002030-199301000-00015

10.1097/01.OLQ.0000086609.95617.8D

10.1128/IAI.00631-06

Krieger JN . Urologic aspects of trichomoniasis. Invest. Urol. 18, 411–417 (1981).

10.1089/aid.2005.21.228

10.1016/j.intimp.2007.04.006

10.1128/AAC.00268-07

10.1038/nm1066

10.1038/nrm2101

10.1126/science.1072994

10.1038/nm1202-793

10.1124/jpet.104.081174

10.1124/jpet.105.100271

10.1124/jpet.106.114330

10.1038/sj.mp.4001967

10.1073/pnas.0603838103

10.1038/35102591

10.1074/jbc.M708754200

10.1084/jem.20080178

10.1038/nm1653

10.1093/nar/22.13.2712

Repp R , BorkhardtA, GossenR, KreuderJ, HammermannJ, LampertF. Construction of RNA standards for high-resolution automatic product analysis in quantitative competitive RT-PCR. Biotechniques19(1), 84–90 (1995).

10.1016/0378-1119(94)00651-8

10.1006/abio.1995.1019

10.1006/abio.1993.1547

10.1002/bio.1170090317

10.1002/(SICI)1098-2825(1996)10:6<423::AID-JCLA19>3.0.CO;2-Z

10.1016/j.bios.2004.03.030

10.1016/j.bios.2004.02.029

10.1016/j.aca.2007.01.018

10.1002/elps.200500009

10.1016/j.jchromb.2006.03.017

10.2116/analsci.22.999

10.1016/j.jpba.2005.01.036

10.1016/S0149-2918(02)80075-3

Purcell RT , LockeyRF. Immunologic responses to therapeutic biologic agents. J. Investig. Allergol. Clin. Immunol. 18, 335–342 (2008).

10.1056/NEJMoa011931

Pendley C , SchantzA, WagnerC. Immunogenicity of therapeutic monoclonal antibodies. Curr. Opin. Mol. Ther. 5, 172–179 (2003).

10.1067/mai.2000.106156

10.1038/417584a

10.1016/S0167-5699(00)01669-8

10.1016/j.ymeth.2005.01.001

FDA. Guidance for Industry: S6 Preclinical safety evaluation of biotechnology-derived pharmaceuticals. C.f.b.e.a. research (Ed.). US Department of Health and Human Services Food and Drug Adminstration. (1997).

10.1016/j.jim.2008.01.001

10.1016/j.jim.2004.06.002

10.1016/j.jpba.2005.04.045

10.1089/adt.2007.089

10.1208/s12248-008-9043-6

10.1177/0091270006292705

10.4049/jimmunol.178.11.7467

10.1016/j.jim.2006.05.011

10.1128/CVI.00157-07

10.1081/IMM-55820

10.1373/clinchem.2005.053348

10.1021/ac061692y

10.1021/ac702628q

10.1128/CVI.00211-07

10.1016/j.jim.2008.10.002

Crowther JR . The ELISA guidebook. In:Methods in Molecular Biology. Humana Press Inc., NJ, USA (2001).

Wild D . The Immunoassay Handbook (3rd Edition). Elsevier Inc., CA, USA (2005).

10.1021/ac702625d

10.1039/b301942j

WHO. Hepatitis C. In: Weekly Epidemiological Record (1999). www.who.int/mediacentre/factsheets/fs164/en/index.html